BA058
Showing 26 - 50 of 97
Ankylosing Spondyloarthritis Trial in Worldwide (Apremilast tablet 20 mg, Apremilast tablet 30 mg BID, Placebo)
Completed
- Ankylosing Spondyloarthritis
- Apremilast tablet 20 mg
- +2 more
-
Peoria, Arizona
- +102 more
Apr 28, 2020
Dyslexia Trial in Roma (Active tDCS, Sham tDCS)
Completed
- Dyslexia
- Active tDCS
- Sham tDCS
-
Roma, ItalyBambino Gesù Hospital and Research Institute
Jul 19, 2021
Survey Study on Barrett's Esophagus Screening
Recruiting
- Gastroesophageal Reflux Disease
- +2 more
- Primary Care Provider Survey
- +2 more
-
Aurora, Colorado
- +6 more
Jan 20, 2022
Pain, Postoperative Trial in Ann Arbor (Caffeine Citrate, Dextrose Water)
Completed
- Pain, Postoperative
- Caffeine Citrate
- Dextrose Water
-
Ann Arbor, MichiganMichigan Medicine
Sep 9, 2021
Coronary Artery Disease, Ischemia Trial in Baltimore (Computed Tomography Angiography)
Active, not recruiting
- Coronary Artery Disease
- Ischemia
- Computed Tomography Angiography
-
Baltimore, MarylandJohns Hopkins Unversity School of Medicine
Jan 18, 2023
Idiopathic Infantile Hypercalcemia - Mild Form Trial in Toronto (Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension)
Recruiting
- Idiopathic Infantile Hypercalcemia - Mild Form
- Rifampin 150 mg, 300 mg capsules and 25 mg/mL oral suspension
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Aug 30, 2021
Bipolar II Disorder, Most Recent Episode Major Depressive Trial in Kaohsiung city (repetitive transcranial magnetic stimulation
Recruiting
- Bipolar II Disorder, Most Recent Episode Major Depressive
- repetitive transcranial magnetic stimulation (rTMS)
- sham repetitive transcranial magnetic stimulation (rTMS)
-
Kaohsiung city, TaiwanKaohsiungVGH
Aug 16, 2022
Biliary Tract Cancer, Programmed Cell Death 1 Ligand 1 Gene Mutation, Targeted Molecular Therapy Trial in Beijing (Camrelizumab,
Not yet recruiting
- Biliary Tract Cancer
- +3 more
- Camrelizumab
- +2 more
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Jan 20, 2021
Non-Alcoholic Steatohepatitis Trial in Worldwide (EDP-305 Dose 1, EDP-305 Dose 2, Placebo)
Completed
- Non-Alcoholic Steatohepatitis
- EDP-305 Dose 1
- +2 more
-
Chandler, Arizona
- +81 more
Aug 19, 2021
Physiology Trial in Grenoble (Nitrate, Nitrate and L-Arginine, Nitrate and L-Citrulline)
Completed
- Physiology
- Nitrate
- +5 more
-
Grenoble, Rhone Alpes, FranceGrenoble University Hospital
Sep 28, 2021
Intracerebral Hemorrhage, Cerebral Edema, Stroke Hemorrhagic Trial in Winston-Salem (Fingolimod 0.5 mg, Placebo, Standard of
Recruiting
- Intracerebral Hemorrhage
- +4 more
- Fingolimod 0.5 mg
- +2 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Nov 28, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Conditions Influencing Health Status, Social Determinants of Health Trial in San Francisco (Health Advocates Program, 211
Completed
- Conditions Influencing Health Status
- Social Determinants of Health
- Health Advocates Program
- 211 Information Sheet
-
San Francisco, CaliforniaSan Francisco General Hospital
Oct 2, 2020
Smoking, Tobacco, Smoking, Smoking, Cigarette Trial in Philadelphia (7-11, CVS)
Recruiting
- Smoking, Tobacco
- +2 more
- 7-11
- CVS
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Jul 26, 2022
Parkinson Disease Trial in Lund, Cambridge (STEM-PD)
Recruiting
- Parkinson Disease
- STEM-PD
-
Lund, Sweden
- +1 more
Dec 7, 2022
Low Back Pain Trial in Salaya (Active-tDCS priming MCE, Sham-tDCS priming MCE, NMES priming MCE)
Recruiting
- Low Back Pain
- Active-tDCS priming MCE
- +3 more
-
Salaya, Nakhon Pathom, ThailandFaculty of Physical Therapy, Mahidol University
Dec 1, 2021
Cohort With Heart Failure With Preserved Ejection Fraction
Unknown status
- Heart Failure With Preserved Ejection Fraction
- No intervention, observational only
- (no location specified)
Jan 15, 2020
Aortic Valve Stenosis Trial in Athens (Ticagrelor plus ASA, Clopidogrel plus ASA)
Completed
- Aortic Valve Stenosis
- Ticagrelor plus ASA
- Clopidogrel plus ASA
-
Athens, Greece1st Department of Cardiology, Hippokration Hospital
Mar 1, 2021
Asthma Trial in Worldwide (QVM149 150/50/160, QVM149 150/50/80, QMF149 150/320)
Completed
- Asthma
- QVM149 150/50/160
- +4 more
-
Bahia Blanca, Buenos Aires, Argentina
- +402 more
Jul 16, 2020
Hepatocellular Carcinoma Trial in Worldwide (Axitinib (AG-013736), Best Supportive Care, Placebo)
Completed
- Hepatocellular Carcinoma
- Axitinib (AG-013736)
- +2 more
-
Berkeley, California
- +76 more
Dec 20, 2018
Osteoarthritis, Arthritis, Rheumatoid Trial in Worldwide (Celecoxib, Diclofenac + Omeprazole)
Completed
- Osteoarthritis
- Arthritis, Rheumatoid
- Celecoxib
- Diclofenac + Omeprazole
-
Genk, Belgium
- +194 more
Mar 1, 2021
Osteoporosis, Postmenopausal Osteoporosis Trial in Worldwide (Placebo, BA058 80 mcg, teriparatide)
Completed
- Osteoporosis
- Postmenopausal Osteoporosis
- Placebo
- +2 more
-
Lakewood, Colorado
- +27 more
Jan 10, 2017
Acute Ischemic Stroke, Stroke Trial in Leiden (real-time audio-visual feedback)
Terminated
- Acute Ischemic Stroke
- Stroke
- real-time audio-visual feedback
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Center
Sep 28, 2020
Weight Loss Trial in Bogalusa (Ideal Protein Weight Loss Method, Standard Weight Loss)
Completed
- Weight Loss
- Ideal Protein Weight Loss Method
- Standard Weight Loss
-
Bogalusa, LouisianaBogalusa Heart Study Clinic
Oct 5, 2020